CSI Market
Sign In | Register

Acro Biomedical Co Ltd (ACBM) Annual Balance Sheets

Annual · GAAP · USD millions
Access ACBM quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Acro Biomedical Co Ltd manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.00
Security Deposit0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.01
Total Current Assets0.01
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Purchase Deposit For Inventory-
Security Deposit Current-
Total Assets0.01
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.06
Other Liabilities, Current0.33
Deferred Revenue, Current DE0.02
Total Current Liabilities0.40
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Due To Related Party Current-
Total Liabilities0.40
Stockholders' Equity
Deferred Stock Compensation-
Common Stock Value0.06
Additional Paid In Capital Common Stock32.31
Retained Earnings / Accumulated Deficit-32.76
Other Equity0.00
Common Stockholder's Equity-0.39
Total Stockholder's Equity-0.39
Liabilities & Stockholder's Equity0.01
4 historic quarters locked

Sign in to unlock the full Acro Biomedical Co Ltd balance sheet history.

Sign In Create Free Account

About Acro Biomedical Co Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 11, 2026
  • Source: acbm_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-26-000241

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License